The state of Arizona currently has 307 active clinical trials seeking participants for Cancer research studies. These trials are conducted in various cities, including Phoenix, Tucson, Scottsdale and Mesa.
Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer
NCT03383094
Recruiting
The purpose of this study is to compare any good or bad effects of using pembrolizumab (an experimental drug) and radiation therapy (RT), compared to using cisplatin chemotherapy and radiation therapy (RT) in the treatment of patients with head and neck squamous cell carcinoma (HNSCC).
Gender:
All
Ages:
18 years and above
Trial Updated:
05/01/2023
Locations: University of Arizona Cancer Center, Tucson, Arizona
Conditions: Head and Neck Squamous Cell Carcinoma, Cancer, Cancer of Head and Neck, Cancer, Advanced, Cancer, Metastatic, Tumor, Tumor Recurrence, Tumor Neck, Tumor Metastasis, Oral Cancer, Oropharyngeal Cancer, Oropharynx Cancer, Oropharynx Cancer, Stage III, Oropharynx Cancer, Recurrent, Oropharynx Cancer, Metastatic
Register for Updates
Multi-Cancer Early Detection (MCED) of Firefighters
NCT05780957
Recruiting
This study is an an observational prospective cohort research study to explore the performance of new blood and urine tests for the early detection of cancer among firefighters.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/24/2023
Locations: Vincere Cancer Center, Scottsdale, Arizona
Conditions: Cancer
Register for Updates
Blue Light Cystoscopy With Cysview® Registry
NCT02660645
Recruiting
Registry study to gather more information on the current use of Blue Light Cystoscopy with Cysview (BLCC) in urologists' practices.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/27/2023
Locations: Mayo Clinic, Phoenix, Arizona
Conditions: Bladder Cancer
Register for Updates
DNA-Guided Second Line Adjuvant Therapy For High Residual Risk, Stage II-III, Hormone Receptor Positive, HER2 Negative Breast Cancer
NCT04567420
Recruiting
A randomized, Phase II trial of circulating tumor DNA-guided second line Adjuvant therapy for high Residual risk, stage II-III, Estrogen Receptor positive, HER-2 negative breast cancer (DARE)
Gender:
All
Ages:
All
Trial Updated:
03/20/2023
Locations: University of Arizona Cancer Center, Tucson, Arizona
Conditions: Breast Cancer
Register for Updates
New Onset Diabetes Management for Earlier Detection of Pancreatic Cancer (NODMED)
NCT05188586
Recruiting
Bluestar Genomics has developed a non-invasive test that aids in detection of occult pancreatic cancer in patients with new onset type II diabetes (NOD) who are 50 years old or older. The purpose of this study is to evaluate the performance of Bluestar Genomics early-detection pancreatic cancer test in a clinical setting. The study is prospective, longitudinal and interventional; tests will be ordered and results returned to site-investigators. If the test returns a pancreatic cancer signal "det... Read More
Gender:
All
Ages:
50 years and above
Trial Updated:
12/06/2022
Locations: Headlands Research - Scottsdale - PPDS, Scottsdale, Arizona
Conditions: Pancreatic Cancer
Register for Updates
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer
NCT04691804
Recruiting
To evaluate whether Fuzuloparib plus AA-P is superior to placebo plus AA-P as first-line treatment by assessment of radiographic progression-free survival (rPFS) in mCRPC subjects unselected for deoxyribonucleic acid (DNA) damage repair deficiencies (DRD) status (Cohort 1) to evaluate whether Fuzuloparib plus AA-P is superior to placebo plus AA-P as first-line treatment by assessment of rPFS in mCRPC subjects harboring DRD (Cohort 2).
Gender:
Male
Ages:
18 years and above
Trial Updated:
07/28/2022
Locations: Urological Associates of Southern Arizona PC, Tucson, Arizona
Conditions: Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Register for Updates
Metastatic Solid Cancer Clinical Trial
NCT04739618
Recruiting
This study seeks to estimate the potential efficacy of the study treatment, as well as the occurrence of adverse events.
Gender:
All
Ages:
18 years and above
Trial Updated:
02/08/2021
Locations: Vincere Cancer Center, Scottsdale, Arizona
Conditions: Metastatic Cancer
Register for Updates